QLT-0267

N/A

Report date: 2023/10/10 16:11:19
NME

Base Information

Drug NameQLT-0267
Drug Alias NameQLT-0267
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin-linked protein kinase inhibitors
TargetsIntegrin-linked protein kinase
Therapy Area/IndicationsThyroid Carcinoma, Anaplastic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of Texas MD Anderson Cancer Center
Active IndicationsN/A
Inactive IndicationsThyroid Carcinoma, Anaplastic

Other Information

ATC CodeN/A
Related LinksN/A